Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Survey: Nearly half of hypertensives unworried about future CV events

Almost half of U.S. citizens with hypertension are unworried about future CV events like heart attack and stroke, according to a recent survey conducted for the American Medical Association and American Heart Association.

Proton pump inhibitors linked to fatal cases of CVD, CKD, stomach cancer

People who take popular heartburn drugs like Prevacid, Prilosec and Nexium are vulnerable to death from cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer, according to new research published in The BMJ.

Thumbnail

FDA fast-tracks new CV indication for Vascepa

The U.S. FDA on May 29 granted Amarin’s Vascepa (icosapent ethyl) priority review for a supplemental indication that would state the medication reduces cardiovascular risk in addition to helping patients manage elevated triglyceride levels.

Thumbnail

Ultra-processed foods threaten CV health in Western countries

A population-based cohort study out of France has identified a link between the consumption of ultra-processed foods and CVD, with a higher intake of sweet and starchy snacks translating to increased risks for cardiovascular, coronary heart and cerebrovascular diseases.

Thumbnail

Fasting before cholesterol labs is futile, researchers say

It’s unnecessary to fast before a complete cholesterol test, according to new research, especially if the sole intention of that test is to determine a patient’s risk of future cardiovascular events.

COAPT: Patients with HF, mitral regurgitation see better health outcomes with TMVR

A recent analysis of the COAPT trial, published this spring in the Journal of the American College of Cardiology, suggests patients with symptomatic heart failure (HF) and secondary mitral regurgitation (MR) might see better mental and physical outcomes if they’re treated with edge-to-edge transcatheter mitral valve repair (TMVR) in lieu of standard therapy.

Thumbnail

Heart attack victims wait an average of 3 hours to get help—here’s why

Researchers have identified a new barrier to timely care for MI patients: a perceived inability to act that leaves them immobilized and unable to seek professional help, in some cases for an excess of 24 hours.

Some e-cig flavors could be more toxic than others

Smoking flavored e-cigarettes can have a detrimental effect on endothelial function, leaving e-cig users prone to poor vascular health and heart disease, researchers report in the June edition of the Journal of the American College of Cardiology.